{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:24:38Z","timestamp":1792819478991,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-025-01437-3","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:26:02Z","timestamp":1753518362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Status Migrainosus \u2013 A Narrative Review"],"prefix":"10.1007","volume":"25","author":[{"given":"Michellee","family":"Mayers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerusalem","family":"Wogayehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"1437_CR1","doi-asserted-by":"crossref","unstructured":"Chua AL, Grosberg BM, Evans RW. Status migrainosus in children and adults. Headache. 2019;59(9).","DOI":"10.1111\/head.13676"},{"key":"1437_CR2","doi-asserted-by":"crossref","unstructured":"Orr SL. Status migrainosus: one of the most poorly understood but important complications of migraine. Neurology. 2023;100(3):107\u2013108.","DOI":"10.1212\/WNL.0000000000201477"},{"issue":"15","key":"1437_CR3","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1177\/0333102411425960","volume":"31","author":"RP Insinga","year":"2011","unstructured":"Insinga RP, Ng-Mak DS, Hanson ME. Costs associated with outpatient, emergency room and inpatient care for migraine in the USA. Cephalalgia. 2011;31(15):1570\u20135.","journal-title":"Cephalalgia"},{"key":"1437_CR4","unstructured":"International Headache Society. ICHD-3: 1.4.1 Status Migrainosus. https:\/\/ichd-3.org\/1-migraine\/1-4-complications-of-migraine\/1-4-1-status-migrainosus\/. Accessed April 2, 2025."},{"key":"1437_CR5","doi-asserted-by":"crossref","unstructured":"Singh TD, Cutrer FM, Smith JH. Episodic status migrainosus: a novel migraine subtype. Cephalalgia. 2018;38(2):304\u2013311.","DOI":"10.1177\/0333102416686341"},{"key":"1437_CR6","doi-asserted-by":"crossref","unstructured":"VanderPluym JH, Mangipudi K, Mbonde AA,. Incidence of status migrainosus in Olmsted County, Minnesota, United States: characterization and predictors of recurrence. Neurology. 2023;100(3):e255-e263.","DOI":"10.1212\/WNL.0000000000201382"},{"issue":"5","key":"1437_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/head.13767","volume":"60","author":"SL Orr","year":"2020","unstructured":"Orr SL, Turner A, Kabbouche MA, et al. The profile and prognosis of youth with status migrainosus: results from an observational study. Headache. 2020;60(5):878\u201388.","journal-title":"Headache"},{"issue":"3","key":"1437_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1526-4610.1983.hed2303094.x","volume":"23","author":"JR Couch Jr","year":"1983","unstructured":"Couch JR Jr, Diamond S. Status migrainosus: causative and therapeutic aspects. Headache. 1983;23(3):94\u2013101.","journal-title":"Headache"},{"key":"1437_CR9","doi-asserted-by":"crossref","unstructured":"Beltramone M, Donnet A. Status migrainosus and migraine aura status in a French tertiary-care center: an 11-year retrospective analysis. Cephalalgia. 2014;34(8):633\u2013637.","DOI":"10.1177\/0333102414520763"},{"key":"1437_CR10","doi-asserted-by":"crossref","unstructured":"Robblee J, Orlova YY, Ahn AH,. Real-world approaches to outpatient treatment of status migrainosus: a survey study. Headache. 2024;64(8):1040\u20131048.","DOI":"10.1111\/head.14769"},{"issue":"5","key":"1437_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/head.13810","volume":"60","author":"CL Szperka","year":"2020","unstructured":"Szperka CL, Ailani J, Barmherzig R, et al. Migraine care in the era of COVID-19: clinical pearls and plea to insurers. Headache. 2020;60(5):833\u201342.","journal-title":"Headache"},{"issue":"11\u201312","key":"1437_CR12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/03331024211010413","volume":"41","author":"C Tassorelli","year":"2021","unstructured":"Tassorelli C, Diener HC, Silberstein SD, et al. Guidelines of the international headache society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia. 2021;41(11\u201312):1135\u201351. https:\/\/doi.org\/10.1177\/03331024211010413.","journal-title":"Cephalalgia"},{"issue":"4","key":"1437_CR13","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/CON.0000000000000191","volume":"21","author":"TD Rozen","year":"2015","unstructured":"Rozen TD. Emergency department and inpatient management of status migrainosus and intractable headache. Continuum (Minneap Minn). 2015;21(4):1004\u201317.","journal-title":"Continuum (Minneap Minn)"},{"key":"1437_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clineuro.2019.01.007","volume":"178","author":"F Xu","year":"2019","unstructured":"Xu F, Arakelyan A, Spitzberg A, et al. Experiences of an outpatient infusion center with intravenous magnesium therapy for status migrainosus. Clin Neurol Neurosurg. 2019;178:31\u20135.","journal-title":"Clin Neurol Neurosurg"},{"key":"1437_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1526-4610.1990.hed30s2550.x","volume":"30","author":"NH Raskin","year":"1990","unstructured":"Raskin NH. Treatment of status migrainosus: the American experience. Headache. 1990;30:550\u20133.","journal-title":"Headache"},{"key":"1437_CR16","unstructured":"Dihydroergotamine mesylate [prescribing information]. Draxis Specialty Pharmaceuticals, Inc. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/005929s044lbl.pdf. Revised August 2008."},{"issue":"6","key":"1437_CR17","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/head.12835","volume":"56","author":"SL Orr","year":"2016","unstructured":"Orr SL, Friedman BW, Christie S, et al. Management of adults with acute migraine in the emergency department: the American headache society evidence assessment of parenteral pharmacotherapies. Headache. 2016;56(6):911\u201340.","journal-title":"Headache"},{"issue":"4","key":"1437_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/1941874416641467","volume":"6","author":"SY Modi","year":"2016","unstructured":"Modi SY, Dharaiya D, Katramados AM, Mitsias P. Predictors of prolonged hospital stay in status migrainosus. Neurohospitalist. 2016;6(4):141\u20136.","journal-title":"Neurohospitalist"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01437-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:57:30Z","timestamp":1757293050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01437-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01437-3","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"11 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Michellee Mayers: Nothing to report. Jerusalem Wogayehu: Nothing to report. Jessica Ailani: Consulting (Honoraria): Abbvie, Amneal, Bausch and Laumb, Dr. Reddy, Eli Lilly and Company, Pfizer, Lundbeck, Satsuma, Aeon, Merz, Vectura. Grants for clinical trials (to institution): Parema, Pfizer, Lundbeck, ShiraTronic, Ipsen, Merz. Grants for clinical trials (to PI): Mi-Helper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"53"}}